U.S. federal trademark · Serial No. 99644627
Research and development in the field of immunotherapy, cell therapy, gene therapy, and immune cell engineering; biomedical research relating to engineered immune receptors, antibody-dependent cellular cytotoxicity platforms, and targeted immune activation technologies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.